相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The incidence of acute oxaliplatin-induced neuropathy and its impact on treatment in the first cycle: a systematic review
Endale Gebreegziabher Gebremedhn et al.
BMC CANCER (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
A. Grothey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
Allan Ramos-Esquivel
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review
Jeremy N. Pulvers et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin
Lorenzo Di Cesare Mannelli et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
Disease Control, Survival, and Toxicity Outcome After Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Single-Institution Experience
Francesca De Felice et al.
CLINICAL COLORECTAL CANCER (2016)
Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance)
Deirdre R. Pachman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04
Michael J. O'Connell et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration
A. J. M. Beijers et al.
SUPPORTIVE CARE IN CANCER (2014)
Clinical pattern and associations of oxaliplatin acute neurotoxicity
Andreas A. Argyriou et al.
CANCER (2013)
Neoadjuvant-intensified treatment for rectal cancer: Time to change?
Daniela Musio et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status
Thierry Andre et al.
CURRENT COLORECTAL CANCER REPORTS (2013)
OXALIPLATIN/5-FLUOROU RACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
Deyan N. Davidov
JOURNAL OF IMAB (2013)
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients
A. A. Argyriou et al.
ANNALS OF ONCOLOGY (2012)
Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0
Alice P. Chen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2012)
Colorectal cancer screening in Australia: a community-level perspective
Ryan J. Courtney et al.
MEDICAL JOURNAL OF AUSTRALIA (2012)
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
Carlo Aschele et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Comparison of Two Neoadjuvant Chemoradiotherapy Regimens for Locally Advanced Rectal Cancer: Results of the Phase III Trial ACCORD 12/0405-Prodige 2
Jean-Pierre Gerard et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A review on oxaliplatin-induced peripheral nerve damage
Andreas A. Argyriou et al.
CANCER TREATMENT REVIEWS (2008)
Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study
HP Kalofonos et al.
ANNALS OF ONCOLOGY (2005)
A review of oxaliplatin and its clinical use in colorectal cancer
A Grothey et al.
EXPERT OPINION ON PHARMACOTHERAPY (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Superiority of oxaliplatin and fluorouracil-leucovorin compared with either therapy alone in patients with progressive colorectal cancer after irinotecan and fluorouracil-leucovorin: Interim results of a phase III trial
ML Rothenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
